pI: 6.7211 |
Length (AA): 498 |
MW (Da): 56180 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 445 | 4u3j (B) | 1 | 430 | 24.00 | 0 | 1 | 1.16667 | -0.63 |
1 | 452 | 4i4t (A) | 1 | 450 | 20.00 | 0 | 1 | 1.09893 | -0.07 |
2 | 443 | 2btq (B) | 2 | 422 | 28.00 | 0 | 1 | 1.02965 | 0.08 |
2 | 448 | 3cb2 (A) | 3 | 443 | 23.00 | 0 | 1 | 1.16489 | -0.43 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_191806)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_IV009070 | tubulin, putative |
Theileria parva | TP01_0867 | hypothetical protein |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Trypanosoma brucei | beta tubulin | 442 aa | 21.8% | 454 aa | Compounds | References |
Leishmania major | epsilon tubulin, putative | 470 aa | 23.8% | 480 aa | Compounds | References |
Bos taurus | Tubulin beta chain | 445 aa | 21.1% | 459 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Ovis aries | Tubulin alpha 4a | 448 aa | 19.5% | 462 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 21.6% | 463 aa | Compounds | References |
Bos taurus | Tubulin | 445 aa | 21.1% | 459 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Trypanosoma brucei | tubulin gamma chain | 447 aa | 23.5% | 443 aa | Compounds | References |
Rattus norvegicus | Tubulin alpha-1 chain | 451 aa | 19.9% | 462 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 21.6% | 463 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Plasmodium falciparum | alpha tubulin 1 | 453 aa | 22.5% | 463 aa | Compounds | References |
Sus scrofa | Tubulin alpha chain | 451 aa | 20.7% | 463 aa | Compounds | References |
Sus scrofa | Tubulin | 445 aa | 21.4% | 457 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 21.6% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Plasmodium falciparum | tubulin beta chain | 445 aa | 21.2% | 458 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 21.6% | 463 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 22.5% | 463 aa | Compounds | References |
Leishmania major | gamma-tubulin | 447 aa | 24.3% | 473 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 21.4% | 458 aa | Compounds | References |